Image Credit: Fast Company
Every week we track the business, tech and investment trends in CPG, retail, restaurants, agriculture, cooking and health, so you don’t have to. Here are some of this week’s top headlines.
In recent developments, the UK has granted approval for its inaugural CRISPR gene-editing drug, marking a groundbreaking step in the treatment of blood disorders. Anticipation is high as the US is expected to follow suit, potentially approving the innovative therapy later this year. Meanwhile, in the European Union, antitrust regulators have expanded their investigation into potential cartel activities within the food delivery sector. Recent raids have targeted two online food delivery companies headquartered in the EU, signaling a widening scope of concerns an… Read More